StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.52−0.18 (-10.59%)

Close on Nov 17, 2026Market cap $1.17MP/E –Yield –

Jupiter Neurosciences cash

Cash and short-term investments held at the end of each period.

Jupiter Neurosciences's cash was $1.52M at Jun 30, 2026. For fiscal 2025 it was $3.79M, up 0.5% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.79M+0.5%
FY2024Dec 31, 2024$3.77M+13136.6%
FY2023Dec 31, 2023$28.48K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.52M-19.0%
Q1 FY2026Mar 31, 2026$2.36M-12.7%
Q4 FY2025Dec 31, 2025$3.79M+0.5%
Q3 FY2025Sep 30, 2025$723.80K+285985.8%
Q2 FY2025Jun 30, 2025$1.88M+6495.4%
Q1 FY2025Mar 31, 2025$2.71M–
Q4 FY2024Dec 31, 2024$3.77M–
Q3 FY2024Sep 30, 2024$253–
Q4 FY2023Dec 31, 2023$28.48K–

More Jupiter Neurosciences figures

See a number that looks wrong?